Vanda Pharmaceuticals (VNDA) Tops Q2 EPS by 12c
Tweet
Share
E-mailGet Alerts VNDA Hot Sheet
Price: $5.32 +1.92%
Financial Fact:
Total operating expenses: 39.14M
Today's EPS Names:
MSGM, SMID, VISL, More
Financial Fact:
Total operating expenses: 39.14M
Today's EPS Names:
MSGM, SMID, VISL, More
Join SI Premium – FREE
Vanda Pharmaceuticals (NASDAQ: VNDA) reported Q2 EPS of ($0.11), $0.12 better than the analyst estimate of ($0.23).
For earnings history and earnings-related data on Vanda Pharmaceuticals (VNDA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
- This biotech stock offers a buying opportunity: B. Riley
- Freightos Limited (CRGO) Tops Q2 EPS by 3c ; Offers Guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
